-+ 0.00%
-+ 0.00%
-+ 0.00%

KYVERNA THERAPEUTICS HIGHLIGHTS UPDATED MIV-CEL DATA AT EULAR DEMONSTRATING SUBSTANTIAL REDUCTION IN DISEASE ACTIVITY IN ACPA-POSITIVE, TREATMENT REFRACTORY RHEUMATOID ARTHRITIS

Reuters·06/03/2026 12:00:03

Please log in to view news